Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AWK$140.56-1.14(-0.80%)New Jersey American Water and Salem City Celebrate Completion of $21.3 Million PFAS Treatment Project New Jersey American Water and Salem City today celebrated the completion of a $21.3 million PFAS treatment installation project at the Salem Water...[4:45:00 PM ET]NVST$23.58-0.08(-0.34%)Envista Announces Release of 2025 Sustainability Report Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the publication of its 2025 Sustainability Report. The report provides an...[4:34:00 PM ET]APEI$46.17-1.50(-3.15%)American Public Education, Inc. Announces Appointment of Shira Goodman to Board of Directors American Public Education, Inc. (Nasdaq: APEI), the parent company of American Public University System, has appointed Shira Goodman to its board of...[4:33:00 PM ET]RAPP$23.00-2.33(-9.20%)Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement[4:32:13 PM ET]ENS$173.00+3.62(+2.14%)EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market[4:31:00 PM ET]RNST$41.58-0.17(-0.41%)Renasant Corporation to Acquire Commercial Holding Company[4:31:00 PM ET]SKYA$2.92+0.03(+1.04%)Bastion Trading Limited Reaches Agreement with SkyAI for Amendments to Tender Offer and Announces That It Will Tender All of Its SkyAI Securities[4:30:38 PM ET]PGC$45.91+0.13(+0.28%)Peapack-Gladstone Financial Corporation Reports Third Quarter Financial Results[4:30:00 PM ET]CARL$15.42+0.51(+3.42%)Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026[4:30:00 PM ET]GT$4.38+0.07(+1.62%)Goodyear Names Jerome Rouquet Chief Financial Officer The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced that Jerome Rouquet will join the company as chief financial officer (CFO), effective ...[4:30:00 PM ET]DBVT$10.05+0.07(+0.70%)DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026[4:30:00 PM ET]BNY$147.58+0.40(+0.27%)BNY to Speak at the BMO Financials Conference The Bank of New York Mellon Corporation ("BNY") (NYSE: BNY), a global financial services company, today announced that Dermot McDonogh, Chief...[4:30:00 PM ET]APXC$4.90-0.35(-6.67%)Apex Announces Closing of Over-Allotment Option[4:30:00 PM ET]BALL$64.10-0.35(-0.54%)Board Declares Quarterly Dividend Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable December 15, 2026, to...[4:30:00 PM ET]VTOL$40.97+0.67(+1.66%)Bristow Group Announces Third Quarter 2026 Earnings Call Bristow Group Inc. (NYSE: VTOL), a leading global provider of mission-critical aviation services, today announced it will release its third quarter...[4:30:00 PM ET]

PACB · NASDAQ

Pacific Biosciences of California, Inc.

$2.42 +0.17 (+7.56%)

Company overview

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyze biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflows, such as template preparation kits to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprising reagents required for on-instrument, real-time sequencing, including phospholinked nucleotides.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$752M
Employees
575
Headquarters
Menlo Park, CA
Website
pacb.com
CEO
Christian O. Henry
Listed
October 27, 2010
P/E
-5.63
Dividend yield
0.00%

Company financials

Revenue
$160M
Gross profit
$59.3M
Operating income
-$163M
EBITDA
-$146M
Net income
-$129M
EPS
-$0.43
Total assets
$782M
Total debt
$703M
Gross margin
37.08%
Net margin
-80.34%
Earnings yield
-17.77%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

0.981.612.252.893.53
PACB 1D NASDAQ O2.12H2.31L2.08C2.25+0.14 (+6.64%)Vol9.57M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
PACBPacific Biosciences of California, Inc. Press release PacBio to Participate in Upcoming Investor Conferences GlobeNewswire
PACBPacific Biosciences of California, Inc. Stock news Here's Why You Should Hold PacBio Stock in Your Portfolio for Now Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors Zacks Investment Research
PACBPacific Biosciences of California, Inc. Press release PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI GlobeNewswire
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors Zacks Investment Research
PACBPacific Biosciences of California, Inc. Press release PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026 GlobeNewswire
PACBPacific Biosciences of California, Inc. Stock news PacBio Teams With TychoBio to Advance AI-Driven RNA Therapeutics Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news Insider Selling: Pacific Biosciences of California (NASDAQ:PACB) Insider Sells $2,058,244.65 in Stock Defense World
PACBPacific Biosciences of California, Inc. Stock news Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday Benzinga
PACBPacific Biosciences of California, Inc. Press release PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics GlobeNewsWire
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news 3 Biotech Stocks Put Traders Are Targeting Today Schaeffers Research
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push MarketBeat
PACBPacific Biosciences of California, Inc. Stock news Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California, Inc. (PACB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know Zacks Investment Research
PACBPacific Biosciences of California, Inc. Stock news Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue? Zacks Investment Research
PACBPacific Biosciences of California, Inc. Press release PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference GlobeNewswire
PACBPacific Biosciences of California, Inc. Stock news PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test Zacks Investment Research
See more
FAQ

Questions about Pacific Biosciences of California, Inc.

What does Pacific Biosciences of California, Inc. do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyze biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflows, such as template preparation kits to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprising reagents required for on-instrument, real-time sequencing, including phospholinked nucleotides.
What is PACB's market cap?
Pacific Biosciences of California, Inc. (PACB) is a listed stock with a live quote. The latest market cap on this page is $752M.
Where is Pacific Biosciences of California, Inc. headquartered?
Pacific Biosciences of California, Inc. is headquartered in Menlo Park, CA.
How do I get PACB news from the API?
Call GET /v1/news?tickers=PACB. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does PACB news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for PACB, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the PACB price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs